Biotron jumps over 14% on latest HIV Phase 2 results; liquidity notably boosted
Shares in otherwise thinly traded healthcare microcap Biotron Limited (ASX:BIT) jumped 14.6%…
Biotron Limited (ASX:BIT)
About Biotron Limited
Key Information
BIT In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 22/07/2024 | Application for quotation of securities - BIT | 15.35KB | 9.7K |
| 11/07/2024 | Letter to Shareholders | 1006.55KB | 35K |
| 26/06/2024 | Webinar Investors Presentation | 3.99MB | 11K |
| 25/06/2024 | BIOTRON CLINICAL TRIAL RESULTS WEBINAR | 828.97KB | 41K |
| 19/06/2024 | Price Sensitive PS BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives | 711.16KB | 31K |
| 23/05/2024 | Change of Share Registry address | 95.43KB | 2.7K |
| 26/04/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 1MB | 51K |
| 05/04/2024 | Price Sensitive PS POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV | 670.99KB | 104K |